US Stock MarketDetailed Quotes

INMB INmune Bio

Watchlist
  • 8.170
  • +0.260+3.29%
Close Aug 2 16:00 ET
  • 8.170
  • 0.0000.00%
Post 16:02 ET
161.62MMarket Cap-3985P/E (TTM)

INmune Bio Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

INmune Bio Earnings Date

Currency: USD

Period

Q2 FY2024 Earnings

Aug 1, 2024

Revenue(YoY)

0.00

-100.00%
EPS(YoY)

-0.50

-38.89%
Analyst Rating

Strong Buy

Jul 31, 2024

INmune Bio Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 0.000--
--2024/Q3-- / 0.000--
Aug 1, 20242024/Q20.000 / 4.670K--
May 9, 20242024/Q114.000K / 14.000K--
Mar 28, 20242023/Q428.000K / 14.330K--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 0.000--
--2024/Q3-- / 0.000--
Aug 1, 20242024/Q20.000 / 4.670K--
May 9, 20242024/Q114.000K / 14.000K--
Mar 28, 20242023/Q428.000K / 14.330K--

Unlock Free Earnings Estimates

INmune Bio Earnings Reports

  • INmune Bio | 10-Q: Quarterly report

    Aug 1 16:07 ET

  • INmune Bio | 10-Q: Quarterly report

    May 9 17:14 ET

  • INmune Bio | 10-K/A: Annual report (Amendment)

    Apr 16 16:07 ET

  • INmune Bio | 10-K: Annual report

    Mar 28 16:12 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jul 31, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg